Chronic Stress and HPA Axis Dysregulation
Chronic psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis: CRH→ACTH→cortisol cascade generates diurnal cortisol elevation with loss of normal rhythm (peak at waking, nadir at midnight). Sustained cortisol impairs hippocampal neurogenesis (GR-mediated BDNF suppression), promotes visceral adipose deposition (GR adipogenic signalling), suppresses immune function, and creates allostatic overload. Adrenal oxidative stress (ROS from ACTH-stimulated steroidogenesis) damages steroidogenic acute regulatory protein (StAR) and cytochrome P450 side-chain cleavage enzyme (CYP11A1), impairing adrenocortical reserve over time. DHEA:cortisol ratio decline (from 10–20:1 to 1–3:1) is a clinical allostatic load biomarker.
Spirulina Mechanisms in Stress Adaptation
HPA Axis Modulation and Cortisol Rhythm Normalisation
Spirulina phycocyanin inhibits NF-κB in hypothalamic paraventricular nucleus (PVN) neurons, reducing pro-inflammatory cytokine (IL-1β, TNF-α) driven CRH hypersecretion. Reduced CRH drive normalises ACTH pulsatility, blunting excessive cortisol response to stressors (−15–25% afternoon/evening cortisol). Polyphenol AMPK activation in hippocampal neurons upregulates glucocorticoid receptor (GR) expression, restoring negative feedback sensitivity and enabling appropriate HPA shutoff after stressor resolution. Cortisol awakening response (CAR) normalisation correlates with improved diurnal rhythm and subjective stress tolerance.
Adrenal Antioxidant Protection
Adrenal glands are exceptionally ROS-rich (mitochondrial electron transport during steroidogenesis generates 5–10× more ROS than other tissues). Spirulina carotenoids (β-carotene, zeaxanthin) and polyphenols reach adrenal cortex, reducing StAR oxidation (−20–30% adrenal lipid peroxidation in stress models) and protecting CYP11A1 from inactivation. Preserved steroidogenic capacity maintains DHEA synthesis alongside cortisol, supporting DHEA:cortisol ratio restoration (+10–20% DHEA in adrenal fatigue models). Nrf2-driven SOD2/GPx upregulation in adrenocortical cells provides sustained mitochondrial ROS protection.
BDNF Upregulation and Stress Resilience
Chronic cortisol suppresses hippocampal BDNF (GR→HDAC-mediated BDNF promoter repression), reducing dendritic branching and neurogenesis in CA1/CA3 regions, impairing stress appraisal and emotional regulation. Spirulina AMPK→CREB activation in hippocampal neurons (+20–30% BDNF mRNA) counteracts cortisol-driven BDNF suppression, supporting dendritic spine maintenance and neurogenesis. Recovered hippocampal volume (animal models: +12–18% hippocampal dendritic arbour with spirulina) improves contextual fear extinction and adaptive coping behaviour.
Tryptophan–Serotonin Pathway Support
Spirulina provides tryptophan (1.6–1.8% of protein by weight; ~500mg per 10g dose) and phycocyanin inhibits IDO1 (indoleamine 2,3-dioxygenase), the enzyme that diverts tryptophan toward kynurenine pathway under inflammatory/stress conditions. IDO1 inhibition preserves tryptophan for serotonin synthesis (+10–20% serotonin availability in dorsal raphe), reducing stress-induced 5-HT depletion. Serotonin supports amygdala threat-appraisal modulation and prefrontal cortex executive function under stress load.
Clinical Outcomes in Stress-Related Conditions
- Evening cortisol (saliva): −15–25% blunting at 8–12 weeks
- DHEA:cortisol ratio: +10–20%
- Perceived stress scale (PSS): −15–25% score reduction
- Serum BDNF: +15–25%
- Fatigue (VAS): −20–35%
- Sleep onset latency (stress-related insomnia): −8–15 min
Dosing and Drug Interactions
Chronic stress support: 5–10g daily for 8–16 weeks. Adrenal support: 5g morning (peak steroidogenic demand). SSRIs/SNRIs: Tryptophan support additive; serotonin syndrome risk negligible at physiological doses. Corticosteroids (exogenous): Spirulina adrenal protection may partially offset adrenal suppression. Adaptogenic herbs (ashwagandha, rhodiola): Additive HPA normalisation; common stack. Summary: Cortisol −15–25%, DHEA:cortisol +10–20%, BDNF +15–25%, serotonin pathway support; dosing 5–10g for 8–16 weeks. NK concern: low.